# US 2023/0069191 A1 · Method for quantitating nucleic acid library

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0069191 A1
- Document ID: US20230069191A1
- Status: Published application
- Kind: A1
- Application number: 17/796,558
- Filed: 2021-01-29
- Published: 2023-03-02
- Earliest claimed: 2020-01-31
- Assignees: Edge Biosystems, Inc.
- Applicants: Edge Biosystems, Inc.
- Inventors: Richard Fekete; Lei Xi
- Web page: https://patentgrep.com/patent/US20230069191A1

## CPC

- C12Q 1/6823: Release of bound markers
- C40B 40/06: Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- C12Q 1/6851: Quantitative amplification
- C12Q 2600/16: Primer sets for multiplex assays
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A method for quantitating a plurality of nucleic acid molecules is provided. The method includes contacting a plurality of detectably-labeled probes and a plurality of extension primers with the plurality of nucleic acid molecules, each detectably-labeled probe including a first labeled nucleic acid domain having a first label; producing an extension product of each of the plurality of target nucleic acid fragments by extending a respective one of the plurality of extension primers with a polymerase; hydrolyzing each of the plurality of detectably-labeled probes hybridized to the respective one of the target nucleic acid fragments during extending the respective one of the plurality of extension primers with the polymerase; detecting a first signal produced as a result of hydrolyzing the plurality of detectably-labeled probes; and calculating a number of the plurality of target nucleic acid fragments based on signals detected upon a single cycle of extension reactions.

## Claims

### Claim 1

A method for quantitating a plurality of nucleic acid molecules comprising a plurality of target nucleic acid fragments, the method comprising:
contacting a plurality of detectably-labeled probes and a plurality of extension primers with the plurality of nucleic acid molecules, wherein each of the plurality of detectably-labeled probes comprises a first labeled nucleic acid domain comprising a first label;
producing an extension product of each of the plurality of target nucleic acid fragments by extending a respective one of the plurality of extension primers with a polymerase;
hydrolyzing each of the plurality of detectably-labeled probes hybridized to the respective one of the target nucleic acid fragments during extending the respective one of the plurality of extension primers with the polymerase;
detecting a first signal produced as a result of hydrolyzing the plurality of detectably-labeled probes; and
calculating a number of the plurality of target nucleic acid fragments based on signals detected upon extension reactions.

### Claim 2 (depends on 1)

The method of claim 1, wherein calculating the number of the plurality of target nucleic acid fragments is based on the first signal detected upon a single cycle of extension reactions.

### Claim 3 (depends on 1)

The method of claim 1, wherein a total number of hydrolyzed detectably-labeled probes is substantially same as a total number of the plurality of target nucleic acid fragments prior to contacting the plurality of detectably-labeled probes and the plurality of extension primers with the plurality of nucleic acid molecules.

### Claim 4 (depends on 1)

The method of claim 1, wherein, subsequent to initially contacting the plurality of detectably-labeled probes and the plurality of extension primers with the plurality of nucleic acid molecules, and prior to detecting the first signal, no additional cycle of extension reactions is performed other than a single cycle of extension reactions.

### Claim 5 (depends on 1)

The method of claim 1, wherein each of the plurality of target nucleic acid fragments comprises a first adapter sequence, a target insert sequence, and a second adapter sequence;
the first adapter sequence is linked to the second adapter sequence through the target insert sequence;
hydrolyzing each of the plurality of detectably-labeled probes comprises hydrolyzing a detectably-labeled probe hybridized to at least a portion of the first adapter sequence; and
extending the respective one of the plurality of extension primers comprises extending an extension primer hybridized to at least a portion of the second adapter sequence.

### Claim 6 (depends on 1)

The method of claim 1, wherein the plurality of nucleic acid molecules further comprise a plurality of adapter molecules; and
each of the plurality of adapter molecules comprises a first adapter sequence directly linked to a second adapter sequence;
wherein the method further comprises contacting a plurality of hybridizing oligonucleotides with the plurality of nucleic acid molecules;
wherein each of the plurality of hybridizing oligonucleotides comprises a sequence complementary to a contiguous domain of a respective one of the plurality of adapter molecules.

### Claim 7 (depends on 6)

The method of claim 6, wherein each of the plurality of hybridizing oligonucleotides comprises a blocker nucleic acid domain;
subsequent to contacting the plurality of hybridizing oligonucleotides with the plurality of nucleic acid molecules, each of the plurality of hybridizing oligonucleotides hybridizes to the contiguous domain of the respective one of the plurality of adapter molecules, but not to the plurality of target nucleic acid fragments; and
hydrolyzation of each of the plurality of hybridizing oligonucleotides hybridized to the contiguous domain and hydrolyzation of each of the plurality of detectably-labeled probes hybridized to the first adapter sequence of a respective one of the plurality of adapter molecules are blocked by a blocking moiety in the blocker nucleic acid domain.

### Claim 8 (depends on 7)

The method of claim 7, wherein the contiguous domain comprises a portion of the first adapter sequence and a portion of the second adapter sequence directly adjacent to each other.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method of any one of claims 1 to 8, wherein the first signal is a first fluorescent signal, and the signals detected upon the extension reactions are fluorescent signals comprising the first fluorescent signal.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The method of any one of claims 1 to 9, wherein each of the plurality of detectably-labeled probes further comprises a second labeled nucleic acid domain comprising a second label;
the first labeled nucleic acid domain is a first reporter domain;
the second labeled nucleic acid domain is a first quencher domain; and
the plurality of detectably-labeled probes are hydrolyzed to release at least one of the first label or the second label.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The method of any one of claims 1 to 9, wherein each of the plurality of detectably-labeled probes further comprises a second labeled nucleic acid domain comprising a second label;
the first label and the second label are two spectrally similar or identical reporters; and
the plurality of detectably-labeled probes are hydrolyzed to release at least one of the first label or the second label.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The method of any one of claims 1 to 9, wherein the first labeled nucleic acid domain is a first reporter domain;
each of the plurality of detectably-labeled probes comprises a quenching nucleotide that quenches an energy from the first label in an excited state; and
the plurality of detectably-labeled probes are hydrolyzed to release at least one of the quenching nucleotide or the first label.

### Claim 13 (depends on 7, 8)

The method of any one of claims 7 to 8, wherein each of the plurality of hybridizing oligonucleotides further comprises a third labeled nucleic acid domain comprising a third label;
subsequent to contacting the plurality of hybridizing oligonucleotides with the plurality of nucleic acid molecules, each of the plurality of hybridizing oligonucleotides hybridizes to the contiguous domain of the respective one of the plurality of adapter molecules, but not to the plurality of target nucleic acid fragments;
hydrolyzation of each of the plurality of hybridizing oligonucleotides hybridized to the contiguous domain and hydrolyzation of each of the plurality of detectably-labeled probes hybridized to the first adapter sequence of each of the plurality of adapter molecules are blocked by a blocking moiety in the blocker nucleic acid domain; and
the plurality of hybridizing oligonucleotides are partially hydrolyzed;
wherein the method further comprises detecting a second signal produced as a result of partially hydrolyzing the plurality of hybridizing oligonucleotides; and
the first signal and the second signal are distinguishably detected.

### Claim 14 (depends on 13)

The method of claim 13, wherein each of the plurality of hybridizing oligonucleotides further comprises a fourth labeled nucleic acid domain comprising a fourth label;
the third labeled nucleic acid domain is a second reporter domain;
the fourth labeled nucleic acid domain is a second quencher domain;
the second reporter domain and the second quencher domain are linked by the blocker nucleic acid domain; and
the plurality of hybridizing oligonucleotides are partially hydrolyzed to release at least one of the third label or the fourth label.

### Claim 15 (depends on 13)

The method of claim 13, wherein each of the plurality of hybridizing oligonucleotides further comprises a fourth labeled nucleic acid domain comprising a fourth label;
the third label and the fourth label are two spectrally similar or identical reporters; and
the plurality of hybridizing oligonucleotides are partially hydrolyzed to release at least one of the third label or the fourth label.

### Claim 16 (depends on 13)

The method of claim 13, wherein the third labeled nucleic acid domain is a third reporter domain;
each of the plurality of hybridizing oligonucleotides comprises a quenching nucleotide that quenches an energy from the third label in an excited state; and
the plurality of hybridizing oligonucleotides are partially hydrolyzed to release at least one of the quenching nucleotide or the third label.

### Claim 17 (depends on 13)

The method of claim 13, wherein the first signal is a first fluorescent signal, the second signal is a second fluorescent signal, and the signals detected upon the extension reactions are fluorescent signals comprising the first fluorescent signal and the second fluorescent signal.

### Claim 18 (depends on 6)

The method of claim 6, wherein each of the plurality of hybridizing oligonucleotides comprises a third labeled nucleic acid domain comprising a third label; and
subsequent to contacting the plurality of hybridizing oligonucleotides with the plurality of nucleic acid molecules, each of the plurality of hybridizing oligonucleotides hybridizes to the contiguous domain of the respective one of the plurality of adapter molecules, but not to the plurality of target nucleic acid fragments;
wherein the method further comprises:
producing an extension product of each of the plurality of adapter molecules by extending a respective one of the plurality of extension primers in the extension reactions with the polymerase;
hydrolyzing each of the plurality of hybridizing oligonucleotides hybridized to the contiguous domain and hydrolyzing each of the plurality of detectably-labeled probes hybridized to the respective one of the adapter molecules, during producing an extension product of each of the plurality of adapter molecules;
detecting a second signal produced as a result of hydrolyzing the plurality of hybridizing oligonucleotides; and
the first signal and the second signal are distinguishably detected.

### Claim 19 (depends on 18)

The method of claim 18, wherein each of the plurality of hybridizing oligonucleotides further comprises a fourth labeled nucleic acid domain comprising a fourth label;
the third labeled nucleic acid domain is a second reporter domain;
the fourth labeled nucleic acid domain is a second quencher domain; and
the plurality of hybridizing oligonucleotides are hydrolyzed to release at least one of the third label or the fourth label.

### Claim 20 (depends on 18)

The method of claim 18, wherein each of the plurality of hybridizing oligonucleotides further comprises a fourth labeled nucleic acid domain comprising a fourth label;
the third label and the fourth label are two spectrally similar or identical reporters; and
the plurality of hybridizing oligonucleotides are hydrolyzed to release at least one of the third label or the fourth label.

### Claim 21 (depends on 18)

The method of claim 18, wherein the third labeled nucleic acid domain is a third reporter domain;
each of the plurality of hybridizing oligonucleotides comprises a quenching nucleotide that quenches an energy from the third label in an excited state; and
the plurality of hybridizing oligonucleotides are hydrolyzed to release at least one of the quenching nucleotide or the third label.

### Claim 22 (depends on 18)

The method of claim 18, wherein the first signal is a first fluorescent signal, the second signal is a second fluorescent signal, and the signals detected upon the extension reactions are fluorescent signals comprising the first fluorescent signal and the second fluorescent signal.

### Claim 23 (depends on 5, 6, 7, 8)

The method of any one of claims 5 to 8, and 13-22, wherein the first adapter sequence comprises a first flow cell binding sequence;
the second adapter sequence comprises a second flow cell binding sequence;
wherein, hydrolyzing each of the plurality of detectably-labeled probes comprises hydrolyzing a detectably-labeled probe hybridized to at least a portion of the first flow cell binding sequence; and
extending the respective one of the plurality of extension primers comprises extending an extension primer hybridized to at least a portion of the second flow cell binding sequence.

### Claim 24 (depends on 8)

The method of claim 8, wherein the first adapter sequence comprises a first sequencing primer binding sequence;
the second adapter sequence further comprises a second sequencing primer binding sequence;
the first sequencing primer binding sequence is directly linked to the second sequencing primer binding sequence; and
the contiguous domain comprises a portion of the first sequencing primer binding sequence and a portion of the second sequencing primer binding sequence directly adjacent to each other.

### Claim 25 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)

The method of any one of claims 1 to 24, the method further comprising preparing for solid phase attachment by diluting the plurality of target nucleic acid fragments to a predetermined concentration.

### Claim 26 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)

The method of any one of claims 1 to 25, wherein the plurality of target nucleic acid fragments are a plurality of target double-strand DNA fragments;
wherein, prior to producing the extension product of each of the plurality of target nucleic acid fragments, the method further comprises denaturing the plurality of target double-strand DNA fragments.

### Claim 27

A method for quantitating a plurality of nucleic acid molecules comprising a plurality of target nucleic acid fragments, the method comprising:
contacting a plurality of extension primers and a plurality of nucleic acid binding dye molecules with the plurality of nucleic acid molecules;
producing an extension product of each of the plurality of target nucleic acid fragments by extending a respective one of the plurality of extension primers with a polymerase;
subsequent to producing the extension product of each of the plurality of target nucleic acid fragments, measuring a signal produced by the plurality of nucleic acid binding dye molecules; and
estimating an average size of the plurality of target nucleic acid fragments based on a number of the plurality of target nucleic acid fragments and the signal produced by the plurality of nucleic acid binding dye molecules.

### Claim 28 (depends on 27)

The method of claim 27, further comprising:
contacting a plurality of detectably-labeled probes and the plurality of extension primers with the plurality of nucleic acid molecules, wherein each of the plurality of detectably-labeled probes comprises a first labeled nucleic acid domain comprising a first label;
producing the extension product of each of the plurality of target nucleic acid fragments by extending the respective one of the plurality of extension primers with a polymerase;
hydrolyzing each of the plurality of detectably-labeled probes hybridized to the respective one of the target nucleic acid fragments during extending the respective one of the plurality of extension primers with the polymerase;
detecting a first signal produced as a result of hydrolyzing the plurality of detectably-labeled probes; and
calculating the number of the plurality of target nucleic acid fragments based on signals detected upon extension reactions.

### Claim 29 (depends on 27, 28)

The method of claim 27 or claim 28, wherein estimating an average size of the plurality of target nucleic acid fragments comprises:
determining a correlation factor using signals respectively produced by a plurality of reference nucleic acid libraries;
estimating the average size of the plurality of target nucleic acid fragments according to the following Equation:
Average
⁢
size
=
S
correlation
⁢
factor
×
N
;
wherein S stands for the signal produced by the plurality of nucleic acid binding dye molecules, and N stands for the number of the plurality of target nucleic acid fragments.

### Claim 30 (depends on 27, 28, 29)

The method of any one of claims 27 to 29, wherein the plurality of nucleic acid binding dye molecules are a plurality of double-stranded nucleic acid intercalating dye molecules.

### Claim 31 (depends on 27, 28, 29)

The method of any one of claims 27 to 29, wherein the plurality of nucleic acid binding dye molecules are a plurality of single-stranded nucleic acid dye molecules.

### Claim 32 (depends on 27, 28, 29)

The method of any one of claims 27 to 29, wherein a respective one of the plurality of nucleic acid binding dye molecules is a fluorescence dye selected from the group consisting of ethidium bromide, SYBR Green, SYBR Gold, SYBR Safe, GelRed, GelGreen, and Diamond™ Nucleic Acid Dye.

### Claim 33

A method of sequencing a nucleic acid sample, comprising:
generating a plurality of nucleic acid molecules comprising a plurality of target nucleic acid fragments using a nucleic acid sample;
contacting a plurality of detectably-labeled probes and a plurality of extension primers with the plurality of nucleic acid molecules, wherein each of the plurality of detectably-labeled probes comprises a first labeled nucleic acid domain comprising a first label;
producing an extension product of each of the plurality of target nucleic acid fragments by extending a respective one of the plurality of extension primers with a polymerase;
hydrolyzing each of the plurality of detectably-labeled probes hybridized to the respective one of the target nucleic acid fragments during extending the respective one of the plurality of extension primers with the polymerase;
detecting a first signal produced as a result of hydrolyzing the plurality of detectably-labeled probes;
calculating a number of the plurality of target nucleic acid fragments based on signals detected upon a single cycle of extension reactions;
diluting the plurality of target nucleic acid fragments to a predetermined concentration; and
sequencing at least one portion of the plurality of target nucleic acid fragments.

### Claim 34

A method for quantitating a plurality of nucleic acid molecules comprising a plurality of target nucleic acid fragments and a plurality of adapter molecules, the method comprising:
contacting a plurality of detectably-labeled probes, a plurality of extension primers, and a plurality of hybridizing oligonucleotides with the plurality of nucleic acid molecules, wherein each of the a plurality of detectably-labeled probes comprises a first labeled nucleic acid domain comprising a first label, and each of the a plurality of hybridizing oligonucleotides comprises a blocker nucleic acid domain;
producing an extension product of each of the plurality of target nucleic acid fragments by extending a respective one of the plurality of extension primers with a polymerase;
hydrolyzing each of the plurality of detectably-labeled probes hybridized to the respective one of the target nucleic acid fragments during extending the respective one of the plurality of extension primers with the polymerase; and
detecting a first signal produced as a result of hydrolyzing the plurality of detectably-labeled probes.

### Claim 35 (depends on 34)

The method of claim 34, wherein each of the plurality of hybridizing oligonucleotides comprises a sequence complementary to a contiguous domain of a respective one of the plurality of adapter molecules;
subsequent to contacting the plurality of hybridizing oligonucleotides with the plurality of nucleic acid molecules, each of the plurality of hybridizing oligonucleotides hybridizes to the contiguous domain of the respective one of the plurality of adapter molecules, but not to the plurality of target nucleic acid fragments;
each of the plurality of target nucleic acid fragments comprises a first adapter sequence, a target insert sequence, and a second adapter sequence, the first adapter sequence is linked to the second adapter sequence through the target insert sequence;
each of the plurality of adapter molecules comprises a first adapter sequence directly linked to a second adapter sequence;
hydrolyzation of each of the plurality of hybridizing oligonucleotides hybridized to the contiguous domain and hydrolyzation of each of the plurality of detectably-labeled probes hybridized to the first adapter sequence of a respective one of the plurality of adapter molecules are blocked by a blocking moiety in the blocker nucleic acid domain.

### Claim 36 (depends on 35)

The method of claim 35, wherein the contiguous domain comprises a portion of the first adapter sequence and a portion of the second adapter sequence directly adjacent to each other.

### Claim 37 (depends on 35, 36)

The method of any one of claims 35 to 36, wherein each of the plurality of hybridizing oligonucleotides further comprises a third labeled nucleic acid domain comprising a third label;
subsequent to contacting the plurality of hybridizing oligonucleotides with the plurality of nucleic acid molecules, each of the plurality of hybridizing oligonucleotides hybridizes to the contiguous domain of the respective one of the plurality of adapter molecules, but not to the plurality of target nucleic acid fragments;
hydrolyzation of each of the plurality of hybridizing oligonucleotides hybridized to the contiguous domain and hydrolyzation of each of the plurality of detectably-labeled probes hybridized to the first adapter sequence of a respective one of the plurality of adapter molecules are blocked by a blocking moiety in the blocker nucleic acid domain; and
the plurality of hybridizing oligonucleotides are partially hydrolyzed;
wherein the method further comprises detecting a second signal produced as a result of partially hydrolyzing the plurality of hybridizing oligonucleotides; and
the first signal and the second signal are distinguishably detected.

### Claim 38 (depends on 37)

The method of claim 37, wherein the first signal is a first fluorescent signal, the second signal is a second fluorescent signal, and the signals detected upon the single cycle of extension reactions are fluorescent signals comprising the first fluorescent signal and the second fluorescent signal.

### Claim 39 (depends on 37)

The method of claim 37, wherein each of the plurality of hybridizing oligonucleotides further comprises a fourth labeled nucleic acid domain comprising a fourth label;
the third labeled nucleic acid domain is a second reporter domain;
the fourth labeled nucleic acid domain is a second quencher domain;
the second reporter domain and the second quencher domain are linked by the blocker nucleic acid domain; and
the plurality of hybridizing oligonucleotides are partially hydrolyzed to release at least one of the third label or the fourth label.

### Claim 40 (depends on 37)

The method of claim 37, wherein each of the plurality of hybridizing oligonucleotides further comprises a fourth labeled nucleic acid domain comprising a fourth label;
the third label and the fourth label are two spectrally similar or identical reporters; and
the plurality of hybridizing oligonucleotides are partially hydrolyzed to release at least one of the third label or the fourth label.

### Claim 41 (depends on 37)

The method of claim 37, wherein the third labeled nucleic acid domain is a third reporter domain;
each of the plurality of hybridizing oligonucleotides comprises a quenching nucleotide that quenches an energy from the third label in an excited state; and
the plurality of hybridizing oligonucleotides are partially hydrolyzed to release at least one of the quenching nucleotide or the third label.

### Claim 42

A mixture, comprising:
a plurality of nucleic acid molecules comprising a plurality of target nucleic acid fragments;
a plurality of detectably-labeled probes; and
a plurality of hybridized adapter molecules;
wherein each of the plurality of detectably-labeled probes comprises a first labeled nucleic acid domain comprising a first label;
each of the plurality of target nucleic acid fragments comprises a first adapter sequence, a target insert sequence, and a second adapter sequence;
the first adapter sequence is linked to the second adapter sequence through the target insert sequence;
at least a portion of each of the plurality of detectably-labeled probes is complementary to at least a portion of the first adapter sequence;
wherein each of the plurality of hybridized adapter molecules comprises:
the first adapter sequence;
the second adapter sequence; and
a partially hydrolyzed hybridizing oligonucleotide, at least a portion of which is hybridized to a domain of a respective one of a plurality of adapter molecules;
wherein the first adapter sequence is directly linked to the second adapter sequence; and
the domain comprises a portion of the first adapter sequence and a portion of the second adapter sequence directly adjacent to each other.

### Claim 43 (depends on 42)

The mixture of claim 42, wherein each of the plurality of hybridized adapter molecules further comprises:
one of the plurality of detectably-labeled probes, at least a portion of which is hybridized to at least a portion of the first adapter sequence; and
one of a plurality of extension primers, at least a portion of which is hybridized to at least a portion of the at least a portion of the second adapter sequence.

### Claim 44 (depends on 42)

The mixture of claim 42, wherein each of the plurality of detectably-labeled probes further comprises a second labeled nucleic acid domain comprising a second label;
the first labeled nucleic acid domain is a first reporter domain; and
the second labeled nucleic acid domain is a first quencher domain.

### Claim 45 (depends on 42)

The mixture of claim 42, wherein each of the plurality of detectably-labeled probes further comprises a second labeled nucleic acid domain comprising a second label;
the first label and the second label are two spectrally similar or identical reporters.

### Claim 46 (depends on 42)

The mixture of claim 42, wherein the first labeled nucleic acid domain is a first reporter domain; and
each of the plurality of detectably-labeled probes comprises a quenching nucleotide that quenches an energy from the first label in an excited state.

### Claim 47 (depends on 42)

The mixture of claim 42, wherein the first adapter sequence comprises a first flow cell binding sequence;
at least a portion of each of the plurality of detectably-labeled probes is complementary to at least a portion of the first flow cell binding sequence.

### Claim 48 (depends on 42)

The mixture of claim 42, further comprising a plurality of extension primers;
wherein at least a portion of each of the plurality of extension primers is complementary to at least a portion of the second adapter sequence.

### Claim 49 (depends on 48)

The mixture of claim 48, wherein the second adapter sequence comprises a second flow cell binding sequence; and
at least a portion of each of the plurality of extension primers is complementary to at least a portion of the second flow cell binding sequence.

### Claim 50 (depends on 42, 43, 44, 45, 46, 47, 48, 49)

The mixture of any one of claims 42 to 49, further comprising a plurality of hybridizing oligonucleotides;
wherein each of the plurality of hybridizing oligonucleotides comprises a blocker nucleic acid domain.

### Claim 51 (depends on 50)

The mixture of claim 50, wherein each of the plurality of hybridizing oligonucleotides further comprises a third labeled nucleic acid domain comprising a third label.

### Claim 52 (depends on 51)

The mixture of claim 51, wherein each of the plurality of hybridizing oligonucleotides further comprises a fourth labeled nucleic acid domain comprising a fourth label;
the third labeled nucleic acid domain is a second reporter domain;
the fourth labeled nucleic acid domain is a second quencher domain; and
the second reporter domain and the second quencher domain are linked by the blocker nucleic acid domain.

### Claim 53 (depends on 51)

The mixture of claim 51, wherein each of the plurality of hybridizing oligonucleotides further comprises a fourth labeled nucleic acid domain comprising a fourth label;
the third label and the fourth label are two spectrally similar or identical reporters.

### Claim 54 (depends on 51)

The mixture of claim 51, wherein the third labeled nucleic acid domain is a third reporter domain; and
each of the plurality of hybridizing oligonucleotides comprises a quenching nucleotide that quenches an energy from the third label in an excited state.

### Claim 55

A kit for quantitating a plurality of nucleic acid molecules comprising a plurality of target nucleic acid fragments, wherein each of the plurality of target nucleic acid fragments comprises a first adapter sequence, a target insert sequence, and a second adapter sequence; the first adapter sequence is linked to the second adapter sequence through the target insert sequence;
wherein the kit comprises:
a plurality of detectably-labeled probes;
a plurality of extension primers; and
instructions directing a user to (1) producing an extension product of each of the plurality of target nucleic acid fragments by extending a respective one of the plurality of extension primers with a polymerase; and (2) calculating a number of the plurality of target nucleic acid fragments based on signals detected upon a single cycle of extension reactions;
wherein each of the plurality of detectably-labeled probes comprises a first labeled nucleic acid domain comprising a first label;
at least a portion of each of plurality of the detectably-labeled probes is complementary to at least a portion of the first adapter sequence; and
at least a portion of each of the plurality of extension primers is complementary to at least a portion of the second adapter sequence.

### Claim 56 (depends on 55)

The kit of claim 55, wherein each of the plurality of detectably-labeled probes further comprises a second labeled nucleic acid domain comprising a second label;
the first labeled nucleic acid domain is a first reporter domain; and
the second labeled nucleic acid domain is a first quencher domain.

### Claim 57 (depends on 55)

The kit of claim 55, wherein each of the plurality of detectably-labeled probes further comprises a second labeled nucleic acid domain comprising a second label;
the first label and the second label are two spectrally similar or identical reporters.

### Claim 58 (depends on 55)

The kit of claim 55, wherein the first labeled nucleic acid domain is a first reporter domain; and
each of the plurality of detectably-labeled probes comprises a quenching nucleotide that quenches an energy from the first label in an excited state.

### Claim 59 (depends on 55)

The kit of claim 55, wherein the first adapter sequence comprises a first flow cell binding sequence;
at least a portion of each of the plurality of detectably-labeled probes is complementary to at least a portion of the first flow cell binding sequence.

### Claim 60 (depends on 55)

The kit of claim 55, wherein the second adapter sequence comprises a second flow cell binding sequence; and
at least a portion of each of the plurality of extension primers is complementary to at least a portion of the second flow cell binding sequence.

### Claim 61 (depends on 55)

The kit of claim 55, the kit further comprising a plurality of hybridizing oligonucleotides;
wherein each of the plurality of hybridizing oligonucleotides comprises a blocker nucleic acid domain.

### Claim 62 (depends on 61)

The kit of claim 61, wherein each of the plurality of hybridizing oligonucleotides further comprises a third labeled nucleic acid domain comprising a third label.

### Claim 63 (depends on 62)

The kit of claim 62, wherein each of the plurality of hybridizing oligonucleotides further comprises a fourth labeled nucleic acid domain comprising a fourth label;
the third labeled nucleic acid domain is a second reporter domain;
the fourth labeled nucleic acid domain is a second quencher domain; and
the second reporter domain and the second quencher domain are linked by the blocker nucleic acid domain.

### Claim 64 (depends on 62)

The kit of claim 62, wherein each of the plurality of hybridizing oligonucleotides further comprises a fourth labeled nucleic acid domain comprising a fourth label;
the third label and the fourth label are two spectrally similar or identical reporters.

### Claim 65 (depends on 62)

The kit of claim 62, wherein the third labeled nucleic acid domain is a third reporter domain; and
each of the plurality of hybridizing oligonucleotides comprises a quenching nucleotide that quenches an energy from the third label in an excited state.

### Claim 66 (depends on 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65)

The kit of any one of claims 55 to 65, the kit further comprising a plurality of nucleic acid binding dye molecules.

### Claim 67 (depends on 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The kit of any one of claims 55 to 66, the kit further comprising a polymerase.
